Proton therapy combined with chemotherapy
Showing 1 - 25 of >10,000
Pancreatic Cancer, Proton Therapy Trial in Wiener Neustadt (radiation, drug, procedure)
Recruiting
- Pancreatic Cancer
- Proton Therapy
- Proton Ions
- +4 more
-
Wiener Neustadt, Niederösterreich, Austria
- +1 more
May 17, 2021
Mucosal Melanoma, Sinonasal Melanoma Trial in Shanghai (procedure, radiation, drug)
Recruiting
- Mucosal Melanoma
- Sinonasal Melanoma
- endoscopic surgery
- +2 more
-
Shanghai, Shanghai, ChinaEye& ENT Hospital, Fudan University
Aug 16, 2021
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023
Non Small Cell Lung Cancer Trial in Scottsdale, Rochester (Proton Beam Therapy, Carboplatin, Paclitaxel)
Recruiting
- Non Small Cell Lung Cancer
- Proton Beam Therapy
- +2 more
-
Scottsdale, Arizona
- +1 more
Nov 9, 2022
Advanced Lung Squamous Cell Carcinoma Trial in Chengdu (low-dose radiation therapy and stereotactic body radiation therapy,
Not yet recruiting
- Advanced Lung Squamous Cell Carcinoma
- low-dose radiation therapy and stereotactic body radiation therapy
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Nov 13, 2023
PET-imaging in Squamous Cell Carcinoma Located in Head and Neck
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Intensity Modulated Proton Therapy (IMPT) +/- Chemotherapy
-
Delft, Zuid-Holland, NetherlandsHolland Proton Therapy Centre (HollandPTC)
Apr 1, 2022
Breast Cancer Female Trial (Pyrotinib and Trastuzumab)
Not yet recruiting
- Breast Cancer Female
- Pyrotinib and Trastuzumab
- (no location specified)
Sep 11, 2023
Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Penpulimab injection
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hostipal, Shanghai Jiao Tong University
Oct 7, 2023
Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Chemotherapy Effect
- FOLFOX chemotherapy regimens
- Bevacizumab
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023
Risarg® Combined With Endocrine Therapy or Chemotherapy in
Not yet recruiting
- HR+HER2- Advanced Breast Cancer
- Ribociclib
- Combination chemotherapy
- (no location specified)
Nov 20, 2023
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)
Not yet recruiting
- Breast Neoplasm
- Trilaciclib plus chemotherapy
- Chemotherapy
- (no location specified)
May 8, 2023
Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)
Recruiting
- Esophageal Carcinoma
- Neoadjuvant Immunotherapy
- PD-1 blockade
- +2 more
-
Beijing, Beijing, ChinaQin li
Mar 8, 2023
Colon Cancer, Neoadjuvant Therapy Trial in Hangzhou (Camrelizumab , apatinib and chemo)
Recruiting
- Colon Cancer
- Neoadjuvant Therapy
- Camrelizumab , apatinib and chemotherapy
-
Hangzhou, Zhejiang, ChinaFirst affiliated hospital, Zhejiang University
Jan 27, 2023
Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)
Not yet recruiting
- Cervical Cancer
- Recombinant humanized anti-PD-1 monoclonal antibody injection
- +4 more
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023
Esophagus Cancer Trial in Loma Linda (Proton radiation)
Recruiting
- Esophagus Cancer
- Proton radiation
-
Loma Linda, CaliforniaLoma Linda University Medical Center
Feb 16, 2022
NSCLC, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab and neoadjuvant therapy, surgical resection of lung cancer)
Recruiting
- NSCLC
- Neoadjuvant Therapy
- Serplulimab and neoadjuvant therapy
- surgical resection of lung cancer
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
May 22, 2023
Chemo-induced Nausea and Vomiting Trial (laserpuncture, Sham Laserpuncture)
Not yet recruiting
- Chemotherapy-induced Nausea and Vomiting
- laserpuncture
- Sham Laserpuncture
- (no location specified)
Nov 10, 2023
NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer
- HS-10241+ Almonertinib
- Pemetrexed + Cisplatin /Carboplatin
- (no location specified)
Oct 29, 2023
Esophageal Squamous Cell Carcinoma Trial (Envafolimab, Albumin-Bound Paclitaxel, Carboplatin)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Envafolimab
- +2 more
- (no location specified)
Sep 21, 2022
Nasopharyngeal Carcinoma Trial in Shanghai (Anti-EGFR and PD-1 inhibitor arm)
Recruiting
- Nasopharyngeal Carcinoma
- Anti-EGFR and PD-1 inhibitor arm
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 26, 2023
Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)
Not yet recruiting
- Unresectable Intrahepatic Cholangiocarcinoma
- Camrelizumab
- +4 more
- (no location specified)
Feb 17, 2023
Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)
Not yet recruiting
- Esophageal Carcinoma
- Neoadjuvant Therapy
- Toripalimab
- +3 more
- (no location specified)
Aug 16, 2023
Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)
Not yet recruiting
- Pleural Mesothelioma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 3, 2023
Esophagus Cancer Trial in Tianjin (Camrelizumab, Paclitaxel, Cisplatin)
Recruiting
- Esophagus Cancer
- Camrelizumab
- +2 more
-
Tianjin, Tianjin, ChinaAffiliated Cancer Hospital of Tianjin Medical University
Nov 24, 2022